Voloridge Investment Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-309,404
| Closed | -$10.3M | – | 1257 |
|
|
2025
Q1 | $10.3M | Sell |
309,404
-46,668
| -13% | -$1.55M | 0.04% | 563 |
|
|
2024
Q4 | $12.3M | Buy |
356,072
+69,886
| +24% | +$2.4M | 0.04% | 517 |
|
|
2024
Q3 | $11.4M | Sell |
286,186
-49,239
| -15% | -$1.97M | 0.04% | 544 |
|
|
2024
Q2 | $10.1M | Sell |
335,425
-10,801
| -3% | -$326K | 0.04% | 554 |
|
|
2024
Q1 | $11.6M | Sell |
346,226
-65,578
| -16% | -$2.2M | 0.04% | 452 |
|
|
2023
Q4 | $13.3M | Buy |
411,804
+142,637
| +53% | +$4.61M | 0.05% | 409 |
|
|
2023
Q3 | $8.82M | Buy |
269,167
+19,045
| +8% | +$624K | 0.04% | 489 |
|
|
2023
Q2 | $8.8M | Buy |
250,122
+146,937
| +142% | +$5.17M | 0.04% | 499 |
|
|
2023
Q1 | $3.37M | Buy |
103,185
+98,999
| +2,365% | +$3.23M | 0.02% | 803 |
|
|
2022
Q4 | $231K | Sell |
4,186
-19,214
| -82% | -$1.06M | ﹤0.01% | 1369 |
|
|
2022
Q3 | $1.04M | Sell |
23,400
-36,113
| -61% | -$1.6M | 0.01% | 1154 |
|
|
2022
Q2 | $2.9M | Sell |
59,513
-133,460
| -69% | -$6.51M | 0.02% | 890 |
|
|
2022
Q1 | $9.39M | Buy |
192,973
+139,433
| +260% | +$6.78M | 0.05% | 428 |
|
|
2021
Q4 | $2.28M | Buy |
+53,540
| New | +$2.28M | 0.01% | 1025 |
|